Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02022982
Title PALBOCICLIB + PD-0325901 for NSCLC & Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Dana-Farber Cancer Institute
Indications

lung non-small cell carcinoma

Advanced Solid Tumor

Therapies

Palbociclib + PD-0325901

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST